De Novo Scan, Clinical Thermography is categorized under Alternative Healing in Scottsdale, AZ and active since 2012.
De Novo Scan, Clinical Thermography was established in 2012, and today employs 1 to 4, earning Unknown per year. This is a Alternative Healing business, which does work in the B2C market, and is classified as a Alternative Healing, under code number by the NAICS.
If you are seeking more information, feel free to contact Tina Clemmons at the company’s single location by writing to 8075 E. Morgan Trail
Suite 1, Scottsdale, Arizona AZ 85258 or by phoning (480) 284-2222. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | De Novo Scan, Clinical Thermography |
| Contact Person: | Tina Clemmons |
| Address: | 8075 E. Morgan Trail Suite 1, Scottsdale, Arizona 85258 |
| Phone Number: | (480) 284-2222 |
| Website Address: | denovoscan.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Alternative Healing |
| Share This Business: |
De Novo Scan, Clinical Thermography was started in 2012 to provide professional Alternative Healing under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Tina Clemmons for inquiries that concern De Novo Scan, Clinical Thermography by calling the company number (480) 284-2222, as your correspondence is most welcome.
Additionally, the physical location of the single location of De Novo Scan, Clinical Thermography can be found at the coordinates 33.5763545,-111.9074686 as well as the street address 8075 E. Morgan Trail
Suite 1 in Scottsdale, Arizona 85258.
For its online presence, you may visit De Novo Scan, Clinical Thermography’s website at denovoscan.com and engage with its social media outlets through on Twitter and on Facebook.